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Multifocalcarcinoidisaknownphenomenon.Wepresentararecombinationofanovariancarcinoidsynchronouswithgallbladder
carcinoid. This rare combination has not been reported so far. An asymptomatic 45-years-old perimenopausal lady was diagnosed
to have a metastatic ovarian cancer, but on laparotomy she was found to have a primary synchronous metastatic gall bladder as
well. On histopathological evaluation she was found to have two separate primary carcinoids. Subsequently the patient received
chemotherapy and is completely asymptomatic on follow up. Further research needs to be undertaken and guidelines need to be
formulated for management of these cases.
1. Introduction
Carcinoid tumors are neuroendocrine tumors derived pre-
dominantly from the enterochromaffin or Kulchitsky cells
[1]. Carcinoid tumors were first described as early as 1888
by Lubarsh, occurring in the small bowel [2, 3]. The overall
incidence of carcinoids is estimated to be approximately 1
to 2/100000 individuals [4]. They may be found anywhere
in the human body but have been described traditionally as
originating from the foregut, midgut, or hindgut.
Multifocal primary disease is rarely known to occur
with carcinoids, although very few cases have been reported
till date. Synchronous primary carcinoid tumors have been
r e p o r t e di na b o u t0 %t o3 %o fs m a l lb o w e lc a r c i n o i d ,a n d
it has been observed that a second primary malignancy
occurs in 7% to 32% of cases [5]. We present a rare case of
synchronousprimarycarcinoidintheovaryandgallbladder,
which has not been reported so far.
2. Case
4 5 - y e a r - o l dp a r a4 ,l i v i n g4p r e s e n t e dt ot h eo u t p a t i e n t
departmentwithchiefcomplaintsofaprogressiveabdominal
distension over the last 5 months and amenorrhea since the 5
p a s t3m o n t h s .A p a r tf r o mt h e s et h ep a t i e n tw a sc o m p l e t e l y
asymptomatic.
On examination the general condition of the patient was
stable and abdominal examination revealed a soft cystic,
nontender abdominopelvic lump, corresponding to 22-week
uterinesize.Thegallbladderwasalsopalpablyenlargedinthe
right hypochondrium. On Speculum examination the cervix
and vagina were healthy, and vaginal examination revealed
bilateral nontender cystic masses with restricted mobility.
Ultrasound showed a left ovarian cystic mass in the iliac
region with the gall bladder showing a localized heteroge-
neous echogenic mass. There was minimal dilatation of the
common bile duct. This was followed by a contrast enhanced
computed tomography scan of the patient that showed a
m u l t i s e p t a t e dm a s sw i t hs o l i da n dc y s t i cc o m p o n e n t si n
the adnexal region till the level of L3. The gall bladder
fossa showed a heterogeneously enhancing lesion but no
lymphadenopathy.
ChestX-ray,uppergastrointestinalendoscopyalongwith
colonoscopywerewithinnormallimits.TheCA-125andCEA
levels were 102.7units/mL and 8.23ng/mL, respectively. Fine
needle aspiration cytology of the mass suggested the features
of epithelial neoplasia. During preoperative evaluation the
malignancyappearedadvanced,andhenceitwasplannedfor2 C a s eR e p o r t si nO b s t e t r i c sa n dG y n e c o l o g y
Figure 1: Section from the ovarian tumor showing nests of cells,
focally arranged in a trabecular pattern, with prominent nuclear
palisading (H and E stain, 10X).
astaginganddebulkingsurgeryasastageIVmalignancy.She
underwent an exploratory laparotomy with total abdominal
hysterectomy, bilateral salpingo o-ophorectomy, infracolic
omentectomy, hepatic resection and, cholecystectomy. The
segment IV B/5 along with the gallbladder was removed.
Intraoperatively there was 200mL of nonhemorrhagic
straw colored ascitic fluid. A right-sided ovarian mass of
20×15cmswithsolidandcysticar easwasnotedalongwitha
leftovarianmassof15×15cms.Theuterusandbilateraltubes
werelookingnormal.Alivernoduleof5×5cmsinsegment5
oncutsectionofthegallbladdermucosawasintactonnaked
eye examination, which later on turned out to be infiltrated
by histopathological examination.
The peritoneal or the ascitic fluid was free of malignant
cells. The right-sided ovarian tumor showed polygonal pleo-
morphic cells with high mitosis and capsular involvement
(Figure 1). Immunohistochemical studies showed expression
of epithelial membrane analyzer, chromogranin A, and neu-
ron specific enolase (Figures 2 and 3), thereby suggesting a
neuroendocrine carcinoma.
The gall bladder also showed similar features of neuroen-
docrine tumor which was positive for EMA, chromogranin
A, and neuron specific enolase. The tumor was infiltrating
the liver, but the margins of the liver nodules were free of the
tumor. Interestingly enough the omentum and lymph nodes,
as well as the ascitic fluid, were free of any malignant cells.
Patient had an uneventful postoperative period. Two
weeks after surgery patient was started on chemotherapy,
which was continued for 5 cycles. She received cisplatin
(20mgs), ifosofamide (2gms) with mesna (400mgs) and
adriamycin (30mgs). The patient has been asymptomatic
during her followup for ongoing chemotherapy.
3. Discussion
The incidence of carcinoids is approximately 0.1% of the
ovarian neoplasms, whereas amongst the carcinoid clan they
are found in 1% of the cases [6].
Carcinoid tumors have a higher incidence in the 5th and
the 6th decades of life. The tumor has a predilection for the
femalegenderandismorecommonintheAfricanAmerican
Figure 2: The tumor cells expressing strong immunoreactivity for
neuron specific enolase (NSE), while the surrounding hepatocytes
are negative.
Figure3:IHCforEMA,stainingthenormalgallbladderepithelium
and the nests of tumor cells infiltrating the wall of the gall bladder.
population [7] .O u rp a t i e n tw a s4 5y e a r so l da tt h et i m es h e
presented with the symptoms.
Carcinoid tumors of the ovary have been classified under
thecategoryofmalignantovariangermcelltumors.Amongst
the malignant germ cell tumors, carcinoids of the ovary
are categorized under the monodermal malignant teratomas.
Primary ovarian carcinoids are most commonly known to
occur unilaterally, in stage I that is not associated with any
metastatic disease [8]. Primary gall bladder carcinoids are
a rare entity with an incidence of less than 1% of all of the
carcinoids [9]. However in our patient there was evidence
of a metastatic liver nodule, which could arise from the gall
bladder.
C a r c i n o i d sa r ea s y m p t o m a t i ci na b o u t4 0 %t o6 0 %o f
cases.Thetypicalsymptomsofcarcinoidsyndromearedueto
theproductionandreleaseofserotonininthesystemiccircu-
lation. Carcinoid syndrome characterized by facial flushing,
diarrhea, bronchospasm, and edema has been observed to
occur in about one third of patients with ovarian carcinoid
tumors[10].Aswiththemajorityofcasesourpatientalsodid
not present with any symptoms pertaining to the carcinoid
syndrome.
Carcinoid tumors are identified on the basis of the
granule-associated proteins chromogranin, synaptophysin,Case Reports in Obstetrics and Gynecology 3
and neuron specific enolase by; mmunohistochemistry [11,
12]. Chromogranin A level is an independent prognostic
factor and elevated levels are associated with poor prognosis
[13]. In our patient, the immunohistochemical studies done
for both the ovarian and the gall bladder malignancies
showed a positivity for the epithelial membrane analyzer,
chromogranin A, and neuron specific enolase hence classi-
fying them into the neuroendocrine group.
The strategies of management would depend not only
on the site, size, and histopathological characteristics of
t h et u m o rb u ta l s ot h es y m p t o m a t o l o g ya n dp r e s e n c eo f
carcinoid syndrome.
The management of an ovarian carcinoid tumor would
range from unilateral salpino-oophorectomy to a total
abdominal hysterectomy. Robby et al. in his study on 10
cases had shown complete remission following unilateral
oophorectomy [10]. Thus in young patients with unilateral
disease, salpingo-oophorectomy is an adequate treatment
[14–16],whereas,incasesofaggressivevariantsofcarcinoidas
goblet cell carcinoid of appendix where there is an increased
risk of metastasis, a prophylactic hysterectomy is advised
[16]. In our patient being of the perimenopausal age group
ar a d i c a lp r o c e d u r ew a sp e r f o r m e d .
Atpresentthereisnoconsensusontheroleofchemother-
a p yi nc a s e so fo v a r i a nc a r c i n o i d .S o m ea u t h o r sb e l i e v et h a t
there is no role of chemotherapy with early stage carcinoid
tumors.
There have been a few case reports of patients with
gynecological literature regarding successful treatment of
advanced ovarian carcinoid following chemotherapy and
radiotherapy. In patients with metastatic disease, chemother-
apy with 5-fluorouracil (5-FU) and leucovorin is offered [7].
The prognosis in our patients is uncertain as this com-
bination has not so far been studied and the patient had
synchronous primary tumors of localized spread to the liver.
Sofarthepatienthasbeenasymptomaticafterthesixmonths
of followup.
4. Conclusion
A very rare case of a synchronous combination of ovarian
with gall bladder carcinoid has been successfully managed
with a multidisciplinary approach; however, long term fol-
lowup still needs to be done. We need to study these
cases more extensively to formulate guidelines for patient
management.
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